PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
Visit https://www.peervoice.com/PKT860 to view the entire programme with slides. After completing “Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?”, participants will be able to: Identify elements of the coagulation cascade that are targets of current hemophilia treatments, including factor replacement therapies and factor mimetics; Recognize the mechanism of action of rebalancing therapies under investigation for the management of hemophilia, including small-interference RNA (siRNA) therapies and tissue factor pathway inhibitors (TFPIs); and Assess the clinical relevance of safety and efficacy data from trials evaluating rebalancing therapies for the treatment of hemophilia A and/or B, including the patient profiles of those included in these trials.